PACB - Pacific Biosciences Director Awarded $677K Worth of Stock Options | Benzinga
David Meline, Director at Pacific Biosciences (NASDAQ:PACB), reported a large acquisition of company stock options on October 16, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Meline, Director at Pacific Biosciences, a company in the Health Care sector, was just awarded stock options worth 86,954 shares of PACB. The options give Meline the right to buy the company's stock at $7.98 per share.
Pacific Biosciences shares are trading down 2.38% at $7.79 at the time of this writing on Monday morning. Since the current price is $7.79, this makes Meline's 86,954 shares worth $677,371.